zilongwang/ReadingBank huggingface dataset:
39/317601 40/317619 41/317627 42/317635 43/317643 44/317774 45/317782 38/316566 Aesculap Germany Lawton GMBH – Germany C&F Euro 269.30 DHS/SUS/939/A/2011 03/478059 10/465810 31/475247 Surgical Suture 180 nos 72 nos 36 nos CovidienPvt Ltd – Singapore USD 696.51 C&F USD 628.93 C&F DHS/LWW/64/12 of 08.11.2011 876778 889933 FACS count control kit Sheath for FACS count 20L/Bottle 1 kit 1 kit 1 kit 1 kit 2 bottles 4 bottles A.Baur& company – Colombo Unit price USD with VAT 510.00 521.00 532.00 543.00 275.00 315.00 DHS/LWW/013/2013 855340 5% Human Albumin solution 250ml infusion bottle 3000 bottles in 250ml Octapharma AG – Switzerland USD C&F 47.50/250ml DHS/LWW/001/12 of 15.03.2011 711009 711033 711122 711198 711245 711287 711300 711326 711431 865167 865175 865183 865191 867753 875031 711130 360 x 500D 190 x500D 324 x 500D 114 x 500D 586 x 500D 262 x 500D 348 x 500D 310 x 500D 174 x 500D 44 x 500D 320 x 500D 372 x 500D 220 x 500D 344 x 500D 94 x500D 372 x 500D Becton Dickinson India Pvt Ltd – India Unit Price (per 500D) USD C&F 15.00 16.30 15.90 13.60 13.30 13.60 15.10 14.40 14.30 14.90 16.40 13.80 14.70 14.20 13.60 16.10
DHS/LWW/066/2012 of 15.11.2011 01/926125 02/926133 03/926159 04/926175 05/926183 06/926191 07/926214 08/926222 09/926230 10/926248 11/926256 12/926272 13/926280 14/926298 15/926303 16/926311 17/926337 18/926345 19/925925 22/925959 23/925967 24/925975 25/925983 26/925991 27/926002 28/926010 29/926028 30/926036 31/926044 32/926060 33/926078 34/926086 35/926094 37/925739 38/925802 39/925810 40/925828 41/925836 42/925844 43/925852 44/925860 45/925878 46/925886 47/925894 04 04 04 06 02 04 02 02 10 02 20 02 02 02 02 02 20 02 07 03 06 06 04 06 02 08 02 04 04 04 04 06 04 22 22 07 07 07 05 05 05 10 08 08 DakoA/S Denmark per vial FOB Euro 293.00 583.00 461.00 1056.00 526.00 589.00 249.00 1034.00 186.00 125.00 186.00 312.00 423.00 125.00 342.00 503.00 211.00 744.00 404.00 342.00 559.00 526.00 310.00 442.00 404.00 749.00 830.00 404.00 805.00 310.00 745.00 310.00 372.00 76.00 95.00 249.00 270.00 249.00 461.00 310.00 310.00 1079.00 1079.00
48/925909 49/925917 50/926264 52/958009 53/948923 54/948915 55/948779 56/948787 57/948795 59/948818 60/948826 61/948834 62/948842 63/948850 64/948868 65/948876 66/948884 67/948892 68/947634 69/948509 70/948452 05 05 02 02 02 25 02 02 02 02 02 02 02 02 02 10 02 02 04 20 10 261.00 713.00 310.00 372.00 293.00 310.00 186.00 336.00 589.00 577.00 483.00 681.00 310.00 274.00 466.00 589.00 1008.00 526.00 783.00 466.00 190.00 186.00
STATE PHARMACEUTICALS CORPORATION OF SRI LANKA TENDER DECISION AS AT 31ST MAY 2012 DHS SURGICAL UNIT Tender Ref: SR/ Item Quantity Supplier Value DHS/SUS/64/F/2012 of 03/08/2012 09/559067 10/559114 34/559821 75 nos 01 no 500 nos Medtronic Trading NL BV – Netherlands Unit C&F US$ 820.00 Free of Charge US$ 615.00 DHS/SUS/20J/2012 of 31.05.11 03/577099 04/577104 05/577112 06/577120 Surgical Consumable 300 nos 700 nos 910 nos 860 nos India Medtronic Pvt Ltd – India Unit C&F US$ 138.00 US$ 128.00 US$ 128.00 US$ 131.00 02/595631 Disposable Apheresis Kit for Haemonetic Apheresis Machine Model MCS + Sterile 1390 Kits EmarPharmaPvt Ltd – Sri Lanka Unit delivered price USD 149.50 less 12% vat DHS/SUS/16/A/2012 of 01.06.2011 01/547808 27/547701 28/547036 39/547387 40/547395 Surgical Consumables 08 nos 06 nos 10 nos 02 nos 02 nos Edward Lifesciences Pvt Ltd – India Unit C&F US$ 3,000.00 US$ 1,900.00 US$ 1,900.00 FOC FOC DHS/SUS/20J/12 of 31/05/2011 07/577170 08/577188 12/577382 13/577413 Surgical Consumables 300 nos 824 nos 1075 nos 760 nos Medtronic Pvt Ltd – India Unit C&F US$ 138.00 US$ 128.00 US$ 120.00 US$ 35.00 12
CERTIFICATE LEVEL: EMERGENCY ASSESSMENT Learning Outcomes Competency Learning Outcomes Competency Is able to evaluate and take control of an emergency situation through a scene survey. U A G Is able to identify the mechanism of injury. U A G U A G U A G U A G U A G U A G U A G Is able to conduct a primary survey including C-Spine stabilization technique, ABC, neuro scan, and a secondary survey. U A G Is able to provide injury specific intervention by selecting appropriate tests to adequately stress the injured part and is able to perform test accurately. U A G U A G U A G U A G U A G U A G U A G Demonstrates an organized, logical approach to assessment. U A G Is able to determine and present a reasonable differential diagnosis. U A G U A G U A G U A G U A G U A G U A G Is able to communicate the plan for follow-up care to the athlete and any others involved. U A G Is able to determine an athlete's readiness to return to play following the published Return to Play guidelines within 5 minutes. U A G U A G U A G U A G U A G U A G U A G Notes:
List of DOT Selective Placement Coordinators Office of the Secretary, Departmental Office of Human Resource Management Duronne Walker, Ph.D. Departmental Selective Placement Program Manager Phone: (202) 366-5305 Office of the Secretary, Resources Operations (OST, M-16) Elizabeth Jenkins Human Resources Specialist Phone: (202) 366-3405 Federal Aviation Administration (FAA, AHP-200) Cesar Collantes Human Resource Specialist (202) 267-7015 Federal Highway Administration (FHWA) Eleni Triantafell Human Resources Specialist Phone: (202) 366-1753 Federal Motor Career Safety Administration (FMCSA) Lisa Horne Human Resources Specialist Phone: (202) 366-7515 Federal Railroad Administration (FRA) Renee Clark Human Resources Specialist Phone: (202) 493-6117 Federal Transit Administration (FTA) Shanina McRae Human Resources Specialist Phone: (202) 493-0605 Maritime Administration (MARAD) Rosetta Simon Human Resources Specialist Phone: (202) 366-0708 National Highway Transportation Safety Administration Terrance Webster Human Resources Specialist Phone: (202) 366-5544 Office of Inspector General (OIG) Joanne Pittman Human Resources Specialist (202) 366-6239 Office of the Secretary for Research and Technology (OST-R) Linda Riggins Human Resources Liaison Phone: (202) 366-0277 Pipeline and Hazardous Materials Safety Administration (PHMSA) Stephen Pearch Human Resources Specialist Phone: (202) 366-3072 Lawrence Seaway Development Corporation (SLSDC) Julie Barnes Human Resources Specialist Phone: (315) 764-3245 VOLPE Center Arthur Bakis Human Resources Specialist Phone: (617) 494-2450
The benefit of this Bond shall not be assignable by the Authority and upon its ceasing to be in full force and effect the Authority shall return the same to the Bidder. This Bond shall be governed by the laws of ( ) I executed as a Deed this( )day of ( )20( ) For and on behalf of the Bidder ……………… … For and on behalf of the Surety……………. ……………………………………………………… ………………………………………………… Signed by ………………………………………… Signed by …………………………………… In the capacity of ……………………………….. and by ………………………………………. in the capacity of ……………………………. In the capacity of …………………………… Seal (where applicable). Seal (where applicable).
5 9/9 Lecture “Selecting & Researching Topic” & “Outlines, Storyboards & Speaking Notes” Read Ch. 3 and 4 6 9/11 Outline Workshop Informative Outlines Due 7 9/16 Exam 1 (Chapter 1-6 and in-class lectures) Lecture “Effective Use of Visual Aids” & “Delivering Your Message” Read Ch. 5 and 6 8 9/18 PowerPoint workshop Informative PowerPoint Slides Due 9 9/23 Lecture “Communication Apprehension” Read Ch. 7 10 9/25 Informative Speeches Group 1 11 9/30 Informative Speeches Group 2 Read Ch. 8 and 9 12 10/2 Informative Speeches 3 13 10/7 Informative Speeches Group 4 Read Ch. 10 and 11 10/9 No Class – Faculty Work Day 14 10/14 Informative Speeches Group 5 Read Ch. 12 and 13 15 10/16 Exam 2 (Chapters 7-13 and in-class lectures) Lecture “Perfecting Language Style” Inf. Self-Evaluations Due 16 10/21 Lecture "Persuasive Theory" & "Methods of Persuasion" Read Ch. 14 and 15 17 10/23 Persuasive "Choose Your Topic" discussion & workshop 18 10/28 Lecture "Analyzing Your Audience" Read Ch. 16 and 17 19 10/30 Persuasive Outline Workshop Persuasive Outlines Due 20 11/4 Lecture “Supporting Your Ideas” Read Ch. 18 and 19 21 11/6 Persuasive Inoculation Workshop 22 11/11 Persuasive PowerPoint Workshop Read Ch. 20 and 21 Persuasive PowerPoints Due 23 11/13 Persuasive Speeches Group 5 24 11/18 Persuasive Speeches Group 4 Read Ch. 22 and 23 11/20 NO Online Assignment 25 11/25 Persuasive Speeches 3 Online Assignment Due Read Ch. 24
Class 1 – Wednesday 10th January 2018 Class 2 – Wednesday 17th January 2018 Class 3 – Wednesday 24th January 2018 4 – Wednesday 7th February 2018 Class 5 – Wednesday 14th February 2018 Reflecting on and Evaluating your Teaching in Higher Education Facilitator: Dr Cicely Roche Time: 10:00 - 12:00 Venue: Room 1.03, 3-4 Foster Place Class 1 – Monday 15th January 2018 Class 2 – Monday 22nd January 2018 Class 3 – Monday 29th January 2018 Class 4 – Monday 5th February 2018 Class 5 – Monday 12th February 2018 6 – Monday 19th February 2018 Embedding Reflection in the Curriculum Facilitators: Dr Cicely Roche & Mr Kevin O’Connor Time: 12:00 – 14:00 Venue: Room 1.03, 3-4 Foster Place Class 1 – Tuesday 27th February 2018 Class 2 – Tuesday 6th March 2018 Class 3 – Tuesday 20th March 2018 Class 4 – Tuesday 10th April 2018 Class 5 – Tuesday 24th April 2018 Class 6 – Tuesday 1st May 2018 Perspectives on Teaching and Learning in Higher Education (previously called Introduction to teaching in Higher Education) Facilitator: Dr Michael Wride Time: 10:00 – 12:00 Room 1.03, 3-4 Foster Place Class 1 –Wednesday 14th March 2018 Class 2 –Wednesday 21st March 2018 3 –Wednesday 28th March 2018 Class 4 –Wednesday 11th April 2018
Module 10 10: T his module is aimed at academics or academic-related professionals who teach and support student learning and who may be at different stages of their career: both those looking to start out teaching in a creative way and those intending to develop their own practice in a more creative direction. Creativity, including imagination, insight, and intuition are all involved in research, but are not necessarily acknowledged when teaching. This emphasis on ‘facts’ tends to ‘fix’ knowledge in place and denies the creative dynamism associated with the processes of learning. There is also a challenge to overcome the ‘fear’ of both students and lecturers of ‘letting go’ sufficiently to allow the creative process to unfold, to step into a place of ‘not knowing’ how things might develop. This module will enable teachers in higher education to clarify and reflect on their own conceptions of, and approaches to, creativity in teaching and learning. Through both individual and collaborative enquiry, it will enable them to reflect on the extent to which they are being creative in both their personal and teaching roles, and enable them to apply theories and philosophies of creativity to the principles of teaching and learning and curriculum development in their discipline. It will introduce practical creative strategies for stimulating more creative thinking in both small and large group teaching, and explore opportunities for more creative assignments and assessments that involve and engage students in creative learning processes. The role of social media and
Module 13 13: t Te objective of embedding reflection within the curriculum is a key component of the Trinity Education project (TEP). This module will enable participants to critically and systematically about their teaching and assessment of reflection/ reflective practice, exploring both the realities of its practice and the pedagogies that guide it, and including ‘hands on’ introduction to relevant web 2 technologies (journals, blogs and wikis). On successful completion of this module participants should be able to: On successful completion of this module participants should be able to: Critically discuss the importance of student reflection as a means to enhance student learning and development. Critique a variety of taxonomies, models and frameworks related to student reflection. Use and critique the role of Web 2.0 technologies (journals, and blogs) in facilitating student reflection. Present a sample of embedding reflection/ reflective practice. Apply methods of evaluation to samples of embedding reflection/reflective practice. Inform [your] teaching of reflection/ development of student reflection through critical awareness of the literature of teaching and learning. Engage with other teachers in higher education in critical discussion related to ‘embedding reflection in the curriculum’.
intrusions into the AOA. Fencing and other markings that are inadequate to separate construction areas from open AOA create aviation hazards. Improper or inadequate marking or lighting of runways (especially thresholds that have been displaced or runways that have been closed) and taxiways that cause pilot confusion and provide a potential for a runway incursion. Inadequate or improper methods of marking, barricading, and lighting of temporarily closed portions of AOA create aviation hazards. □ Wildlife attractants — such as trash (food scraps not collected from construction personnel activity), grass seeds, tall grass, or standing water — on or near airports. □ Obliterated or temporary markings on active operational areas. □ Misleading or malfunctioning obstruction lights. Unlighted or unmarked obstructions in the approach to any open runway pose aviation hazards. □ Failures to issue, update, or cancel NOTAMs about airport or runway closures or other construction related airport conditions. □ Failure to mark and identify utilities or cables. Damage to utilities and power cables during construction activity can result in the loss of runway / taxiway lighting; loss of navigation, visual, or approach aids; disruption of weather reporting services; and/or loss of communications. □ Restrictions on ARFF access from fire stations to the runway / taxiway system or airport buildings. □ Lack of communications with construction vehicles in airport movement areas. □ Objects, regardless of whether they are marked or flagged, or activities anywhere on or near an airport that could be distracting, confusing, or alarming to pilots during aircraft operations. □ Water, snow, dirt, debris, or other contaminants that temporarily obscure or derogate the visibility of runway/taxiway marking, lighting, and pavement edges. Any condition or factor that obscures or diminishes the visibility of areas under construction. □ Spillage from vehicles (gasoline, diesel fuel, oil) on active pavement areas, such as runways, taxiways, aprons, and airport roadways. □ Item Action Required or None
(B-16) (B-17) (B-18) For band center frequency . (B-19) Let (B-20) (B-21) (B-22) (B-23) Let = acceleration power spectral density at the center of the plate = uniform pressure power spectral density (B-24) (B-25)
Baton Rouge Community College Academic Affairs Master Syllabus Date Approved: 5 May 2016 Course Name: Registrar: 3-0-3 Lec-Lab-Credit: BRCC Course Rubric: State Common Course Rubric: 2016: Prior to 2016: CIP Code Lecture: Lab: Course: Contact Hrs/Wk: Contact Hrs/Wk: Contact Hrs/Term Credit hours: Credit hours: Credit Hours: Course Description: Prerequisites: Co-requisites: Suggested Enrollment Cap: Learning Outcomes: Upon successful completion of this course, the students will be able to: 1. 2. 3. 4. 5. General Education Learning Outcomes: This course supports the development of competency in the following areas. Students will: Assessment Measures: Assessment of all learning outcomes will be measured using the following methods: 1. 2. 3.
Strategic Planning Committee Minutes – January 24, 2018 Attendees: S. Marsh, J. Koprowski, S. Bonar, R. Gallery, M. McClaran, D. Breshears, B. Steidl, S. Archer, L. Lopez-Hoffman, K. Hughes, W. van Leeuwen, B. Krogsgaard, A. Stewart, L. Fera, C. Brocka Approval of previous meeting's notes from January 17, 2018 S. Marsh's Director's Report and Discussion: Accountant interviews update: second interviews are this week NPC External Review: will be in April, we will be arranging the external reviewer's visit (NIH and National Cancer Institute) J. Koprowski's trip with the Dean: dean sees SNRE as the next growth opportunity in CALS WUE – university decision, not an ABOR decision, follow up with Dean Staten POP Job Ad – approved by CALS and is being reviewed by HR now, student evaluations will not be required for the initial application, we will see if they can be asked of the finalists UA Online Tier 1 Call for Proposals – will discuss with Bill Smith about using course for both in person and online Unit heads and budgets – B. Krogsgaard, J. Koprowski and S. Marsh will be reviewing the accounts in the school to see who controls it and how it's being used. Special Topics Community Colleges Initiative Cochise College – S. Marsh will be doing another visit to their classes, Clara Miller and Betsy Grube to also attend. Was also invited to attend the Science Career Day for high school students in Sierra Vista Eastern Arizona College – no response Where to go next? Scottsdale Community College, Eastern Arizona College (Alex Smallwood transferred from EAC), Central Arizona Community College, Kingman SNRE survey – M. McClaran: to see when SNRE students decide to make degree options so we can formulate a recruiting plan. K. Hughes – possibly do two surveys, one for SNRE students and one for other students interested in the sciences but who are not current SNRE students. Also, how are freshmen picking their major?
The college should be making improvements based on student learning outcomes assessment, and we need to continue to document and share the improvements and progress you have already made. This is extremely important. Did you make any changes in your CLO statements during the last 4-year cycle that ended in 2012, or any changes this year? Please explain what you accomplished. Did you make any improvements in the areas of teaching and instruction processes, your courses, or your program? Please explain and provide details about your efforts! Yes, changes have been made to our CLO statements. on discussions, we determined some courses had too many outcomes. The following CLO changes were made during this period: * SPCOM 100 CLOs were rewritten to demonstrate clear and measurable outcomes. * SPCOM 102 CLO #2 was changed to reflect a singular rather than dual focus. * 104 CLOs were rewritten to demonstrate clear and measurable outcomes. * SPCOM 106 CLOs were rewritten to demonstrate clear and measurable outcomes. * SPCOM 122 CLO #3 was changed to create a more measurable outcome. * SPCOM 123 CLO #4 was eliminated due to its immeasurability. * SPCOM 130 CLOs were rewritten to demonstrate clear and measurable outcomes. Also, during the spring 2012 semester, the Speech Communication faculty established a Communication Studies Lab. The primary goal of the lab is to support student success in Speech Communication courses. The department uses the lab to help students develop presentation outlines, conduct academic research, practice presentations, and reduce communication apprehension. The Communication Studies Lab attendance increased from Spring 2012 to Spring 2013 at a rate of 117% (57 to 124 students). Room utilization of the practice rooms increased from Spring 2012 to Spring 2013 at a rate of 97.5% (125 to 247 students). We are currently working at maximum capacity in the lab and are seeking an alliance with the Integrated Learning Center to increase lab hours in order to serve more students. This relationship will also help faculty assess the impact of the lab in a more organized and comprehensive manner.
and carer at the centre of care delivery, e.g. patient care pathways and commissioning frameworks. with and from patients, service users and carers. a flexible approach, utilising generic models of learner support, information, guidance, feedback and assessment across the placement circuit in order to support the achievement of placement learning outcomes for all learners. Ensure effective use of available support, information and guidance, reflect on all learning experiences, including feedback given, and be open and willing to change and develop on a personal and professional level. Offer a learning infrastructure and resources to meet the needs of all learners, ensuring that all staff who supervise learners undertake their responsibilities with the due care and diligence expected by their respective professional and regulatory body and organisation Comply with placement policies, guidelines and procedures, and uphold the standards of conduct, performance and ethics expected by respective professional and regulatory bodies and organisations. Respond to feedback from all learners on the quality of the placement experience to make improvements for all learners. Evaluate the placement to inform realistic improvements, ensuring that informal and formal feedback is provided in an open and constructive manner. • ‘Learner’ refers to all health, education and social care students, trainees, hosted learners. • ‘Placement’ relates to all learning environments / work based learning experiences. • ‘Mentor’/ ‘placement educator’ relates to all trainers / supervisors / coordinators appropriately qualified / suitably prepared to support learners. • ‘Professional and regulatory body and organisation’ relates to standards required to ensure patient and public safety, and professional behaviours. Developed in the North West by healthcare learners, service users, carers, and health and social care staff from all professions in the North West region. Health Education North West
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Felidale 1.25 mg coated tablets for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 tablet contains: Active substance: Thiamazole 1.25 mg Excipients: Titanium Dioxide (E171) 0.51 mg Dispersed Ponceau 4R Lake (E124) 1.35 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Coated tablet. Red biconvex tablets 5.5 mm diameter. 4. CLINICAL PARTICULARS 4.1 Target species Cats. 4.2 Indications for use, specifying the target species For the stabilisation of hyperthyroidism in cats prior to surgical thyroidectomy. For the long-term treatment of feline hyperthyroidism. 4.3 Contraindications Do not use in cats suffering from systemic disease such as primary liver disease or diabetes mellitus. Do not use in cats showing of autoimmune disease. Do not use in animals with disorders of blood cells, such as neutropenia and lymphopenia. Do not use in animals with platelet disorders and coagulopathies (particularly thrombocytopenia). Do not use in cats with hypersensitivity to thiamazole or the excipient, polyethylene glycol. Do not use in pregnant or lactating females. Please refer to section 4.7.
6. PHARMACEUTICAL PARTICULARS 6.1 List of excipients Tablet core: Lactose monohydrate Povidone Sodium starch glycolate Magnesium stearate Coating: Sucrose Povidone Dispersed Ponceau 4R Lake (E124) Macrogol Talc White beeswax Carnauba wax Shellac Titanium dioxide (E171) Sodium methyl hydroxybenzoate (E219) 6.2 Major Incompatibilities None known. 6.3 Shelf life Tub: Shelf life of the veterinary medicinal product as packaged for sale: 3 years. Blister: Shelf life of the veterinary medicinal product as packaged for sale: 2 years. 6.4 Special precautions for storage Do not store above 25C. Tub: Keep the container tightly closed in order to protect from moisture. Keep the container in the outer carton. Blister: Keep the blister strips in the carton. 6.5 Nature and composition of immediate packaging Tub: White polypropylene tub with white low density polyethylene tamper evident lid containing 100 tablets. Blister: Transparent PVC/Aclar – aluminium blister. Blister strips contain 25 tablets. Each carton contains 4 blister strips. 6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products Any unused veterinary medicinal product or waste material derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Boehringer Ingelheim Animal Health UK Limited Ellesfield Avenue Bracknell Berkshire RG12 8YS United Kingdom 8. MARKETING AUTHORISATION NUMBER Vm 08327/4210 9. DATE OF FIRST AUTHORISATION 29 January 2004 10. DATE OF REVISION OF THE TEXT November 2018 Approved: 16 November 2018
Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious. Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations. Handle this product with great care to avoid exposure, taking all recommended precautions. If you develop symptoms following exposure such as a skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing, are more serious symptoms and require urgent medical attention. Wash hands after use. Adverse reactions (frequency and seriousness) Use of the product may occasionally result in pain on injection and/or local tissue reactions. Use during pregnancy, lactation or lay The product may be used in pregnant animals, subject to observance of the withholding time for milk and the withdrawal time for meat intended for human consumption. Interaction with other medicinal products and other forms of interaction None known. Amounts to be administered and administration route By either intramuscular or subcutaneous injection in dogs and cats, and by intramuscular injection only in cattle and pigs, at a dosage rate of 8.75 mg/kg bodyweight (1 ml / 20 kg bodyweight) daily for 3-5 days. Shake the vial well before use. After injection, massage the injection site. Use a completely dry sterile needle and syringe. Swab the septum before removing each dose. For combined therapy, the following minimum treatment regime should be followed: Synulox RTU Synulox LC 8.75 mg/kg bodyweight (7.0 mg amoxicillin, 1.75 mg clavulanic acid) i.e. 1 ml/20 kg bodyweight One syringe gently infused into the teat of the infected quarter
From 3 months of age Rispoval IBR-Marker vaccine used Revaccination intervals Primary vaccination (number of doses and route of administration) Interval to first booster vaccination (vaccine and route of administration) All subsequent booster vaccinations (vaccine and route of administration) Vivum (one dose, intramuscular) 6 months (Vivum, intramuscular) 6 months (Vivum, intramuscular) Vivum (one dose, intramuscular) 6 months (Inactivatum, subcutaneous) 12 months (Inactivatum, subcutaneous) Inactivatum (two subcutaneous, with 3-5 week interval) 6 months (Inactivatum, subcutaneous) 6 months (Inactivatum, subcutaneous) For female cattle for protection against abortion: Rispoval IBR-Marker vaccine used Revaccination Vaccination schedule (number of doses and route of administration) recommended to be applied no later than by the start of second trimester of pregnancy Vivum (two doses, intramuscular, with 3-5 weeks interval) Inactivatum (one dose, subcutaneous) recommended to be applied no than by the start of the second trimester of each pregnancy Vivum (one dose, intramuscular) followed by Inactivatum (one dose, subcutaneous), with 6 months interval Inactivatum (two doses, subcutaneous, with 3-5 week interval)
PLEASE NOTE: Because different classes are affected differently by meeting times, holidays and individual class dynamics, this schedule is subject to change. Week Holidays Reading Quizzes Other Points XC 1 8/14- 8/20/2017 LAST DAY TO DROP 8/18 Syllabus Review Syllabus Syllabus Quiz 20 SPC Syllabus Addendum SPC Honesty Policy Applied Ethics Student Questionnaire (Pre-Test) Applied Ethics Student Questionnaire (Pre-Test) Drop Box 5 Dialogue Decalogue Objective Moral Truth UN Declaration of Human Rights US Constitution Amendments Objective Truth (writing sample) 100 2 N/A The Foundations of Ethics Chapter 1 Chapter 1 20 The Ethics Environment Chapter 2 Chapter 2 20 3 8/28- 9/3/2017 N/A Dimensions of Moral Development Chapter 3 Chapter 3 20 Critical Thinking Chapter 4 Chapter 4 20 Critical Thinking Exercises CTE: Identification CTE: Identification 20 4 Labor Day 9/4 Critical Thinking CTE: Research CTE: Research 30 5 N/A Critical Thinking
Lactation: The safety of the veterinary medicinal product has not been established in lactating sows, thus its use is not recommended during lactation. Fertility: Do not use in breeding animals. 4.8 Interaction with other medicinal products and other forms of interaction The absorption of doxycycline can be reduced in the presence of high amounts of Ca2+, Fe3+, Mg2+ or Al3+ in the diet. Do not administer together with antacids, kaolin and iron preparations and in conjunction with bactericidal antibiotics like 4.9 Amounts to be administered and administration route To be administered orally, in medicated feeding stuff. The premix is administered directly mixed with feed according to the following dose: 10-12 mg of doxycycline/kg bodyweight/day, equivalent to 80-95 mg of the product/kg bodyweight/day. Treatment should be continued for 8 days. the intake of feed will vary depending on the clinical condition of the animals, in order to obtain the correct dosage the concentration of doxycycline has to be adjusted accordingly. To calculate the dosage of the veterinary medicinal product, the following formula could be used as an example: mg of veterinary medicinal product per kg of feed = 80 – 95 mg veterinary medicinal product/kg b.w./day x mean body weight (kg) of animals to be treated Mean daily feed intake/animal (kg) To ensure a correct dosage body weight should be determined as accurately as possible to avoid underdosing. The recommended incorporation rate into feed would be 2 kg of the veterinary medicinal product per tonne of feed. The required doses should be measured by suitably calibrated weighing equipment. 4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary Not described. 4.11 Withdrawal period(s) Pigs for fattening: Meat and offal: 5 days
possible. The route of administration depends on the age and weight of the individual and can be intravenous (vena cava cranialis or ear vein) or intracardiac. The injection duration can - depending on the age and body weight of the pig –vary from 1 second (piglets) and 38 seconds (in boars> 100 kg body weight). Intravenous (ear vein) by rapid injection after dilution with isotonic (0.9%) NaCl solution at a ratio of 1:1 Intracardiac (in unconscious or deeply sedated/anaesthetised patients) 0.16 ml/kg up to 30 kg 0.08 ml/kg over 30 kg 0.16 ml/kg up to 30 kg 0.08 ml/kg over 30 kg 80 mg /kg up to 30kg 40 mg /kg over 30kg 80 mg /kg up to 30kg 40 mg /kg over 30kg Dogs&Cats Intravenous; slow continuous injection untilunconscious then rapid injection of remaining quantity Intracardiac &intraperitoneal: in unconscious or deeply sedated/anaesthetised patients per 4 kg Dog 1.0 ml per 3 kg Cat 1.0 ml per 3 kg Dog 1.0 ml per 2 kg Cat 125 mg/kg Dog 166 mg/kg Cat 166 mg/kg Dog 250 mg/kg Cat Mink, polecats Intravenous Intracardiac (in unconscious or deeply sedated/anaesthetised patients) per animal 500 mg per animal Hares, rabbits, guinea pigs, hamsters, rats, mice Intravenous Intracardiac (in unconscious or deeply sedated/anaesthetised patients) Intraperitoneal (in unconscious or deeply sedated/anaesthetised patients) per 1.5 kg 1.0 ml per 1kg 333 mg/kg 500 mg/kg Chickens, pigeons, ornamental birds The method of choice in is intravenous injection.If venepuncture cannot be Intravenous&Intrapulmonary(in unconscious or deeply sedated/anaesthetised patients) 1.0 ml per 1 kg 500 mg/kg
PLANNING APPLICATIONS 2018/2019 No. Location Proposal Application No. Selwood Parish Council Recommendation Yes/No MDC Decision Approved Yes/No 1. 2 Cuckoo Lane, Frome, BA11 2NS Proposed conversion of existing outbuilding into annex ancillary accommodation for elderly parent to include new pitched tiled roof, proposed new timber framed and clad carport and external store. 2018/0480/HSE No reason(s) to object. Selwood P.C. Meeting 11.04.18. Yes – with conditions. 2. Sainsbury’s Supermarket, Wessex Fields, Marston Road, Frome, BA11 4DH Erection of new and replacement signage, 1 No. totem, 4 No. vinyl overlay, 2 No. Fascia box and 4 No. welcome panels. 2018/0755/ADV No reason(s) to object. Selwood P.C. Meeting 23.05.18. Yes – with conditions. 3. Woodlands Farm, East Woodlands Road, Blatchbridge, Frome, BA11 5EL Erection of Rural Workers Dwelling with removal of temporary Rural Workers Dwelling following construction. 2018/0710/FUL No reason(s) to object. Selwood P.C. Meeting 23.05.18. Yes – with conditions. 4. 33 Vinney Lane, Blatchbridge, Frome, BA11 5EH Proposed 3 storey side extension to existing 3 storey terraced cottage. 2018/0751/HSE No reason(s) to object. Selwood P.C. Meeting 23.05.18. Yes – with conditions.
Frome, BA11 5BN. including 1 No. mobile home, No 1 touring caravan, 1 No. day room, septic tank and hardstanding. narrow lane which is unsuitable for a lot of traffic movement and very close to existing residential properties. There can be no access from Vinney Lane onto the A361 as this is a very busy trunk road and the only access would be via Bulls Quarries Road. Also, it was noted that sewage would be disposed of via a septic tank – councillors are of the opinion that if planning consent is granted, a treatment plant should be incorporated as opposed to a septic tank as the property is in very close proximity to a river – perhaps MDC Planning should refer this issue to their consultant engineer with expertise in such matters. Selwood P.C. Meeting 04.07.18. 11. Feltham Farm, Feltham Hill, Frome, BA11 5NA Prior approval for a proposed change of use of an agricultural building to a ‘larger’ dwelling house (class 3) and for associated operational development. 2018/1346/PAA Selwood P.C. has not received any notification of this application and is not included in the list of Consultees for comments. discussion it was felt by councillors that a full planning application should be submitted in respect of this proposed development – this is not a traditional farm building with a stone construction but a rigid steel barn used for the storage of hay. The parish council are of the opinion that this application does not meet the criteria of ‘Prior Approval’. Selwood P.C. Meeting 04.07.18. Awaiting decision.
Rating Remark Trend Remark Credit Risk Medium Continued watch for macro and impact to portfolio. Currently, no noticeable issues. Portfolio risk is satisfactory. Only one loan substantially at risk for loss approximating RMB 1.1MM. Portfolio is concentrated in software, which includes digital content, and advertising. Stable Portfolio remains in satisfactory condition. Some longer cycles of Company fundraising as entrepreneurs and investors adjust to slowing or reduced valuation growth. Fundraising environment is still satisfactory and opportunities are plentiful, but investors are still selective. Market Risk Medium Loan growth and deposit campaign lower the net interest income sensitivity. Continued RMB depreciation. Stable Remains within the tolerance aligned with our business strategy. However, more volatility in the market is expected in the future. Liquidity Risk Medium Liquidity overall is good due to capital base, however RMB Loan to Deposit ratio continues to have volatility due to competitive nature for deposits. The deposit campaign has helped to lower the concentration in the deposit base to the historically lowest level. The growth in loans has kept pressure on the liquidity. Increasing Expect continued pressure on RMB Loan to Deposit Healthy pipeline of loan opportunities will necessitate continued deposit focus. Other opportunities to seek deposits are being explored, but will require some infrastructure development. Plan to convert portion of USD capital to RMB to provide cushion. Operational Risk Medium Operational was stable during the year with no Increasing Constant evaluation of systems and operational processes will be focused for future business
CONTRACT ACTION SUMMARY FORM CONTRACT NUMBER: Contract Information: State Entity Date Supplier Name Supplier ID Contract Number Date Contract Title NIGP Code(s) Contract Type: Open Statewide Contact Information: State Entity Supplier Contract Administrator Contact Name Street Street City State: City State Zip Zip Phone Phone Email Email Business Owner Small Business Yes No Georgia Small Resident Yes No Phone Georgia Resident Yes No Georgia Manufactured Yes No Email Performance Period: Initial Term: Effective Date: Expiration Date: Renewal Options (if any): Exercised 1st Renewal? Yes No Renewal Period: through Exercised 2nd Renewal? Yes No Renewal Period: through Exercised 3rd Renewal? Yes No Renewal Period: through Exercised 4th Renewal? Yes No Renewal Period: through CONTRACT NAME: NUMBER: Bonds (if any): Department of Revenue Tax Compliance Initial Value Renewal Period: Initial Clearance
$ Date: Confirmed 1st Renewal? Yes No through 1st Renewal Yes No $ Date: Confirmed 2nd Renewal? Yes No through 2nd Renewal Yes No $ Date: Confirmed 3rd Renewal? Yes No through 3rd Renewal Yes No $ Date: Confirmed 4th Renewal? Yes No through 4th Renewal Yes No $ Date: Insurance (if any): eVerify/ Immigration Form Initial Value Renewal Period: Initial Clearance $ Date: Confirmed 1st Renewal? Yes No through 1st Renewal Yes No $ Date: Confirmed 2nd Renewal? Yes No through 2nd Renewal Yes No $ Date: Confirmed 3rd Renewal? Yes No through 3rd Renewal Yes No $ Date: Confirmed 4th Renewal? Yes No through 4th Renewal Yes No $ Date: Amendment(s)*: Amendment Number: Effective Date: Brief Description: Amendment Number: Effective Date: Brief Description: Amendment Number: Effective Date: Brief Description: *Amendments continue on subsequent pages Contract Out: CONTRACT NAME: NUMBER: Effective Date: Reason for Contract Close Out: Supplier Completed Performance Terminated for Convenience Contract Expired Terminated for Cause Terminated for Lack of Funding
2 Months are counted from the start of the assignment/mobilization. One (1) month equals twenty two (22) working (billable) days. One working (billable) day shall be not less than eight (8) working (billable) hours. 3 “Home” means work in the office in the expert’s country of residence. “Field” work means work carried out in the Client’s country or any other country outside the expert’s country of residence. Full time input Part time input
Consultant’s Representations Regarding and Charges (Model Form I) (Expressed in {insert name of currency*}) Personnel 1 2 3 4 5 6 7 8 Name Position Basic Remuneration Rate per Working Month/Day/Year Social Subtotal Profit2 Away from Home Office Allowance Proposed Fixed Rate per Working Month/Day/Hour Proposed Fixed Rate per Working Home Office Client’s Country {* If more than one currency is used, use additional table(s), one for each currency} 1. Expressed as percentage of 1 2. Expressed as percentage of 4
Additional Comments: Not Approved Decision Date: (mm-dd-yy) Additional Comments: Submission Details After completing the “Piggyback Request” form online, select “Send to mail recipient (as attachment)” from the toolbar. Type Process.Improvement@doas.ga.gov in the “To” field and press “Send”. Note: Upon receipt of all required information to the Process Improvement mailbox as directed above, this request will be processed within five (5) business days. APO/CUPO will be notified promptly of the SPD Deputy Commissioner’s decision.
If a Proposal Security or a Proposal-Securing Declaration is specified pursuant to ITP 32.1, any Proposal not accompanied by a substantially responsive Proposal Security or Proposal-Securing Declaration shall be rejected by the Employer as non-responsive. The Proposal Security of the successful Proposer shall be returned as promptly as possible once the successful Proposer has signed the Contract and furnished the required Performance Security. The Proposal Security may be forfeited or the Proposal-Securing Declaration executed: if a Proposer withdraws its Proposal during the period of Proposal validity specified by the Proposer on the Letter of Proposal or any extension thereto provided by the Proposer; or if the successful Proposer fails to: sign the Contract in accordance with ITP 64; or furnish a performance security in accordance with ITP 65. The Proposal Security or the Proposal-Securing Declaration of a JV shall be in the name of the JV that submits the Proposal. If the JV has not been legally constituted into a legally enforceable JV at the time of submission of Proposals, the Proposal Security or the Proposal-Securing Declaration shall be in the names of all future members as named in the letter of intent referred to in ITP 4.1. If a Proposal Security is not required in the PDS, and: if a Proposer withdraws its Proposal during the period of Proposal validity specified by the Proposer on the Letter of Proposal; or if the successful Proposer fails to: sign the Contract in accordance with ITP 64; or furnish a performance security in accordance with ITP 65. the Employer may, if provided for in the PDS, declare the Proposer disqualified to be awarded a contract by the Employer for a period of time as stated in the PDS.
quality of Technical Proposal in terms of method statement, key personnel, access to key equipment, work program and organization, , and any other activities as specified by the Employer and based on the proposers experience. Any sustainable procurement requirement if specified in Section VII- Employer’s Requirements. (b) Each technical factor may include sub factors as specified in the PDS. The scores to be given to each technical factor and sub criteria are specified in the PDS. TECHINICAL PROPOSAL SCORING METHOLOGY [NOTE TO THE EMPLOYER:. The Employer shall develop a scoring methodology to be included here] If as per PDS 43.2, the technical factors (and sub- factors, if applicable) are weighted in terms of relevance, the total technical score would be the weighted average in percent. The score for each sub- factor (i) within a factor (j) will be combined with the scores of sub- factors in the same factor as a weighted sum to form the Factor Technical Score using the following formula: where: tji = the technical score for sub- factor “i” in factor “j” wji = the weight of sub- factor “i” in factor “j”, k = the number of scored sub-factors in factor “j” and The Factor Technical Scores will be combined in a weighted sum to form the total Technical Proposal Score using the following formula: where: Sj = the Factor Technical of factor “j” Wj = the weight of factor “j” as specified in the PDS n = the number of Factors and
Item Description Qty. Unit Price1 Total Price1 Local Currency Portion Foreign Currency Portion (1) (2) (optional) (1) x (2) TOTAL (to Schedule No. 5. Grand Summary) Name of Proposer Signature of Proposer 1 Specify currency in accordance with specifications in ITP 31. Schedule No. 4. Installation and Services Item Description Qty. Unit Price1 Total Price1 Foreign Currency Portion Local Currency Portion Foreign Local (1) (2) (3) (1) x (2) (1) x (3)
General Conditions of Contract Contract and Interpretation 1. Definitions 1.1 The following words and expressions shall have the meanings hereby assigned to them: “Contract” means the Contract Agreement entered into between the Employer and the Contractor, together with the Contract Documents referred to therein; they shall constitute the Contract, and the term “the Contract” shall in all such documents be construed accordingly. “Contract Documents” the documents listed in Article 1.1 (Contract Documents) of the Contract Agreement (including any amendments thereto). “GCC” means the General Conditions of Contract hereof. “PCC” means the Particular Conditions of Contract. “day” means calendar day. “year” 365 days. “month” means calendar month.
Rockdale Orientation & Planning Mtg for New Districts Identify internal resources, sites, and roles & responsibilities August 21, 2015 1:30pm – 3:30pm Log on to CiscoWebEx Rockdale Baseline data collection Reliable and efficient means of measuring Sept. 15, 2015 TBD – 30 min in each targeted classroom Arrange schedule for
Rockdale SEE-KS: Introductory training (Essential for core team members & open to any related service How Social Neuroscience Informs Critical Skills in Social, Communication & Emotional Development Sept. 24, 2015 8:30am to 3:30 Full Day If full day participation is not feasible, attendance from 8:30am – Confirm location
providers and support staff) 10:00am as an alternative Rockdale (w Cobb, MCS, and APS) SEE-KS – UDL Training (P. 1 of 3) – Web based Fostering Student Engagement – Using SEE-KS in action Oct. 2, 2015 1:00 – 3:30pm (Partial day subs) Arrange location for web meeting with core teams and
partial day coverage Rockdale Coaching Session (Onsite) Achieving student engagement and program fidelity Rockdale Oct. 8, 2015 (March Coach – Schedule for 30 – 45 min observe, 30 - 45 min. mentorship for each classroom; Arrange schedule and floating coverage for teacher to meet
and mentor as well. Rockdale (w Cobb, MCS, and APS) SEE-KS – UDL Training (P. 2 of 3) Mutiple Modes of Instruction Nov. 5, 2015 1:00 – 3:30pm (Partial day subs) Arrange location for web meeting with core teams and
Rockdale Coaching Session (Onsite) Achieving student engagement and program fidelity Jan. 5, 2016 – Bobbie Jo Valenzuela) Schedule for 30 – 45 min observe, 30 - 45 min. mentorship for each classroom; Arrange schedule and floating coverage for teacher to meet following observation.
Rockdale (w Cobb, MCS, and APS) SEE-KS – UDL – Training (P. 3 of 3) Multiple Means of Expression January 14, 2016 1:00 – 3:30pm (Partial day subs) Arrange location for web meeting with core teams and partial day coverage
Victor is planning a weekend out with his friends. Combine elements from each column to describe what everyone is going to do. Ustedes Nosotros Victor Claudio y su primo Tú Yo ver películas ir al estadio de futbol el sol visitar monumentos pasear por el parque comer en el restaurante el domingo el fin de semana al mediodía a las tres por la noche por la mañana 1. 2. 3. 4. 5. 6.
2.3 Information on potential employment Types of employment Enterprise Salary Self- employment Sub-contract Wage Overseas Total Number Percent 100 % Expected monthly income in Rs. 2.4 Name of Potential Employers with contact address SN Name of Employer's firm Address Name of Responsible Person Contact Number Number of people to be employed 1 2 3 4 ...... Support Service Information Summary (Please fill the columns as appropriate and attach evidencing documents) S. No. Support Services How many (Number) How (Procedure) 1 Business skill training
ESHS Management Plan Activity Potential Adverse Impacts Impact Evaluation Mitigation Measures (MM) Responsibility for MM Nature Magnitude Extent Duration Significance 1 2 3 4 5 6 7 8 Note: Nature - D= Direct; IN= Indirect Extent - R= Regional, LC= SS= Site specific Duration - LT= Long term (more than 20 years) (20) MT= Medium term (3-20 years) (10) ST= Short term (less than 3 years) (5)